Notch Inhibitors as a New Tool in the War on Cancer: A Pathway to Watch
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
154-160
Author(s):
Benjamin Purow
Targeting the Tumor Stroma in Cancer Therapy
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
185-191
Author(s):
Kevin Anton and John Glod
Tumor Initiating Cells
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
192-196
Author(s):
Nitu Bansal and Debabrata Banerjee
Cancer Stem Cells: The Emerging Challenge of Drug Targeting
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
394-416
Author(s):
Roger Besancon, Sandrine Valsesia-Wittmann, Alain Puisieux, Claude Caron de Fromentel and Veronique Maguer-Satta
MALDI Mass Spectrometry Imaging, from its Origins up to Today: The State of the Art
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
12
Page:
156-174
Author(s):
Simona Francese, Francesca R. Dani, Pietro Traldi, Guido Mastrobuoni, Giuseppe Pieraccini and Gloriano Moneti
Editorial [Hot Topic:Angiogenesis Agents(Executive Editor: Cezary Marcinkiewicz)]
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
343-344
Author(s):
Cezary Marcinkiewicz
Encountering and Advancing Through Antiangiogenesis Therapy for Gliomas
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
353-364
Author(s):
Vanesa Martin, Dan Liu and Candelaria Gomez-Manzano
Regulation of Angiogenesis by Macrophages, Dendritic Cells, and Circulating Myelomonocytic Cells
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
365-379
Author(s):
Zhao Ming (David) Dong, Alfred C. Aplin and Roberto F. Nicosia
PI-3 Kinase-PTEN Signaling Node: An Intercept Point for the Control of Angiogenesis
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
380-388
Author(s):
R. C. Castellino, C. R. Muh and D. L. Durden
Angiogenic and Vascular Modulation by Extracellular Matrix Cleavage Products
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
389-410
Author(s):
Frank Suhr, Klara Brixius and Wilhelm Bloch